Clinical Trials Logo
  1. Home
  2. Small Fiber Neuropathy
  3. NCT03912220

Evaluation of Nicotinamide Riboside in Prevention of Small Fiber Axon Degeneration and Promotion of Nerve Regeneration

Small Fiber Neuropathy Clinical Trial

Official title:
Evaluation of Nicotinamide Riboside in Prevention of Small Fiber Axon Degeneration and Promotion of Nerve Regeneration

Clinical Trial Summary

This study will evaluate the effects of a nutritional supplement called nicotinamide riboside in preventing small fiber nerve degeneration that is experimentally induced by applying capsaicin to skin in otherwise healthy study participants. Furthermore, the effects on nerve regeneration will also be evaluated. The results will be compared to a placebo control drug.

Clinical Trial Description

Small fiber neuropathy (SFN) is a type of peripheral neuropathy that affects the small unmyelinated fibers, including both somatic innervation of the skin and autonomic nerves. Although diabetes and prediabetes are the two most common causes, up to 50% of all SFN remain idiopathic. Currently there is no effective treatment that prevents it or reverses it through regeneration of nerve fibers. Recent advances in understanding the molecular machinery that mediates Wallerian degeneration (i.e. degeneration of nerve fibers after physical transection) showed that key molecular players in this pathway and nicotinamide (NAD+) metabolites play a similar role in degeneration of axons in a distal-to-proximal manner seen in many peripheral neuropathies including SFN. Pre-clinical studies have shown that rapid depletion of NAD initiates a cascade of molecular events that leads to axon degeneration and that supplementation of a NAD precursor, nicotinamide riboside (NR) can prevent this degeneration. In this study investigators plan to evaluate the ability of NR to prevent degeneration of small somatic sensory axons innervating the epidermis as well as its ability to promote regeneration of these same fibers in a human experimental model of nerve degeneration and regeneration. This experimental human model has been used previously to evaluate the rate of nerve degeneration and regeneration in several peripheral neuropathies and in healthy subjects. Since NR is available as a nutritional supplement, if successful, this research can lead to development of a therapy for a variety of peripheral neuropathies very rapidly. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT03912220
Study type Interventional
Source Johns Hopkins University
Contact
Status Completed
Phase Phase 2
Start date September 1, 2020
Completion date May 30, 2023
View Details
See also
  Status Clinical Trial Phase
Completed NCT02537951 - Autofluorescent Flavoprotein Imaging of Intraepidermal Nerve Fibers: a Pilot Study N/A
Completed NCT01911975 - Safety and Tolerability of Lacosamide in Patients With Gain-of-function Nav1.7 Mutations Related Small Fiber Neuropathy Phase 3
Completed NCT03304522 - A Study to Evaluate the Efficacy and Safety of VX-150 in Treating Subjects With Pain Caused by Small Fiber Neuropathy Phase 2
Recruiting NCT04310644 - Autonomic Small Fiber Neuropathy and Ehlers Danlos Syndromes - Prospective Study and Registry
Completed NCT03401073 - IVIg for Small Fiber Neuropathy With Autoantibodies TS-HDS and FGFR3 Phase 2
Recruiting NCT03889080 - fMRI-study in Patients With Small Fiber Neuropathy
Completed NCT03447756 - Titration Study of ABX-1431 Phase 1
Recruiting NCT04835779 - Biometric and Biological Data for Diagnosis and Therapy of Pain Patients
Suspended NCT04611048 - Establishing Normative Values for Thermal Detection and Pain Threshold Established by the Psi Method N/A
Not yet recruiting NCT04170205 - Causes Associated With Small Fiber Neuropathy (SFN).
Recruiting NCT05389566 - Diabetes, Falls, and Fractures
Terminated NCT03339336 - Efficacy and Safety Study of BIIB074 in Participants With Small Fiber Neuropathy Phase 2
Recruiting NCT05798949 - Chronic Pain Rehabilitation in Patients With Small Fiber Neuropathy N/A
Enrolling by invitation NCT05921097 - Comparison of Histamine and Local Heating for Evoking the Axon-reflex Flare Response in Diabetes
Completed NCT02637700 - Intravenous Immunoglobulin Therapy for Small Fiber Neuropathy Phase 2
Recruiting NCT04759443 - Detection of Small Fiber Neuropathy Using Skin Properties
Terminated NCT02905396 - Spinal Cord Stimulation in Small Fibre Neuropathy N/A
Completed NCT05380804 - Cutaneous Silent Period Assessment in Primary Sjögren's Syndrome
Recruiting NCT03509064 - Medico-economic and Quality of Life Impact of Sjogren-associated Small Fiber Neuropathy
Completed NCT05993871 - Diabetic Small Fiber Neuropathy: Clinical, Electrophysiological and Neurosonographic Study